Shanghai Zhongshan Hospital: Diabetes Mellitus, Type 2 trials
The registry lists 12 Diabetes Mellitus, Type 2 studies with Shanghai Zhongshan Hospital as lead sponsor. 2 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 4 5No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral AgentsRecruitingNCT07307235Phase 4
- Autologous Islet Transplantation for DiabetesEnrolling by invitationNCT07118475Early Phase 1
- Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose MetabolismCompletedNCT04283942Not applicableResults posted
- Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General WardsCompletedNCT06319300Not applicable
- Insulin Titration System Based on Deep LearningCompletedNCT05409391Not applicable
- Canagliflozin and Myocardial FibrosisCompletedNCT05367063Phase 4
- Long-term Effect of Moderate and Vigorous Exercise on Incident Diabetes in Obese SubjectsCompletedNCT05346250
- Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus PatientsCompletedNCT04642378Not applicable
- Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 DiabetesCompletedNCT04374578
- Artificial Intelligence Assisted Insulin Titration SystemCompletedNCT04053959Phase 4
- Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)CompletedNCT04004793Phase 4
- Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT02920801Phase 4